Low Prevalence of Pneumocystis pneumonia (PCP) but High Prevalence of Pneumocystis dihydropteroate synthase (dhps) Gene Mutations in HIV-Infected Persons in Uganda

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Taylor, Steve M ^a,b   Meshnick, Steven R ^a   Worodria, William ^c,d   Andama, Alfred ^c,d   Cattamanchi, Adithya ^c,e   Davis, J Lucian ^c,e   Yoo, Samuel D ^c,f   Byanyima, Patrick ^c   Kaswabuli, Sylvia ^c   Goodman, Carol D ^g   Huang, Laurence ^c,e,h  

^a The University of North Carolina at Chapel Hill   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d MULAGO HOSPITAL   (Uganda)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Health Tutors' College Mulago   (Uganda)

^g SAN FRANCISCO GENERAL HOSPITAL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DAPSONE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PROLINE; SERINE; THREONINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DHPS GENE; FEMALE; FUNGAL GENE; FUNGAL STRAIN; FUNGUS ISOLATION; GENE MUTATION; GIEMSA STAIN; HAPLOTYPE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; SPUTUM SMEAR; TERTIARY HEALTH CARE; UGANDA;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; AZURE STAINS; BASE SEQUENCE; BRONCHOALVEOLAR LAVAGE FLUID; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE, BACTERIAL; HAPLOTYPES; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA; STATISTICS, NONPARAMETRIC; UGANDA;

CORYNEBACTERINEAE; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII;

EID: 84869222750     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049991     Document Type: Article

References (35)

1. Hartung TK, Chimbayo D, van Oosterhout JJ, Chikaonda T, van Doornum GJ, et al. (2011) Etiology of suspected pneumonia in adults admitted to a high-dependency unit in Blantyre, Malawi. Am J Trop Med Hyg 85: 105-112.
2. Ioannidis JP, Cappelleri JC, Skolnik PR, Lau J, Sacks HS, (1996) A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Arch Intern Med 156: 177-188.
3. Iliades P, Meshnick SR, Macreadie IG, (2005) Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs. Antimicrob Agents Chemother 49: 741-748.
4. Meneau I, Sanglard D, Bille J, Hauser PM, (2004) Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae. Antimicrob Agents Chemother 48: 2610-2616.
5. Stein CR, Poole C, Kazanjian P, Meshnick SR, (2004) Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia. Emerg Infect Dis 10: 1760-1765.
6. Matos O, Esteves F, (2010) Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations. Parasite 17: 219-232.
7. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B, (1999) Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 354: 1347-1351.
8. Kazanjian P, Armstrong W, Hossler PA, Burman W, Richardson J, et al. (2000) Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 182: 551-557.
9. van Hal SJ, Gilgado F, Doyle T, Barratt J, Stark D, et al. (2009) Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes. J Clin Microbiol 47: 1818-1823.
10. Valerio A, Tronconi E, Mazza F, Fantoni G, Atzori C, et al. (2007) Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype. J Acquir Immune Defic Syndr 45: 521-528.
11. Navin TR, Beard CB, Huang L, del Rio C, Lee S, et al. (2001) Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study. Lancet 358: 545-549.
12. Ma L, Borio L, Masur H, Kovacs JA, (1999) Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J Infect Dis 180: 1969-1978.
13. Ma L, Kovacs JA, Cargnel A, Valerio A, Fantoni G, et al. (2002) Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis 185: 1530-1532.
14. Dini L, du Plessis M, Frean J, Fernandez V, (2010) High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J Clin Microbiol 48: 2016-2021.
15. Zar HJ, Alvarez-Martinez MJ, Harrison A, Meshnick SR, (2004) Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia. Clin Infect Dis 39: 1047-1051.
16. Taylor SM, Meshnick SR, Worodria W, Andama A, Davis JL, et al. (2011) Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia. Diagnostic Microbiology & Infectious Disease.
17. Alvarez-Martãnez Mr, Mirã J, Valls ME, Moreno An, Rivas P, et al. (2006) Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagnostic microbiology and infectious disease 56: 153-160.
18. Costa MC, Esteves F, Antunes F, Matos O, (2006) Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal. J Antimicrob Chemother 58: 1246-1249.
19. Deok-jong Yoo S, Worodria W, Davis JL, Cattamanchi A, den Boon S, et al. (2010) The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda. J Acquir Immune Defic Syndr 54: 269-274.
20. Worodria W, Davis JL, Cattamanchi A, Andama A, den Boon S, et al. (2010) Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients. Eur Respir J 36: 446-448.
21. Vray M, Germani Y, Chan S, Duc NH, Sar B, et al. (2008) Clinical features and etiology of pneumonia in acid-fast bacillus sputum smear-negative HIV-infected patients hospitalized in Asia and Africa. AIDS 22: 1323-1332.
22. Kamanfu G, Mlika-Cabanne N, Girard PM, Nimubona S, Mpfizi B, et al. (1993) Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am Rev Respir Dis 147: 658-663.
23. Batungwanayo J, Taelman H, Lucas S, Bogaerts J, Alard D, et al. (1994) Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am J Respir Crit Care Med 149: 1591-1596.
24. Kibiki GS, Beckers P, Mulder B, Arens T, Mueller A, et al. (2007) Aetiology and presentation of HIV/AIDS-associated pulmonary infections in patients presenting for bronchoscopy at a referral hospital in northern Tanzania. East Afr Med J 84: 420-428.
25. Aderaye G, Bruchfeld J, Aseffa G, Nigussie Y, Melaku K, et al. (2007) Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia. Scandinavian journal of infectious diseases 39: 1045-1053.
26. Malin AS, Gwanzura LK, Klein S, Robertson VJ, Musvaire P, et al. (1995) Pneumocystis carinii pneumonia in Zimbabwe. Lancet 346: 1258-1261.
27. Worodria W, Okot-Nwang M, Yoo SD, Aisu T, (2003) Causes of lower respiratory infection in HIV-infected Ugandan adults who are sputum AFB smear-negative. Int J Tuberc Lung Dis 7: 117-123.
28. Ng VL, Yajko DM, McPhaul LW, Gartner I, Byford B, et al. (1990) Evaluation of an indirect fluorescent-antibody stain for detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 28: 975-979.
29. Cregan P, Yamamoto A, Lum A, VanDerHeide T, MacDonald M, et al. (1990) Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 28: 2432-2436.
30. Huang L, Beard CB, Creasman J, Levy D, Duchin JS, et al. (2000) Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis 182: 1192-1198.
31. Crothers K, Beard CB, Turner J, Groner G, Fox M, et al. (2005) Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 19: 801-805.
32. Hauser PM, Nahimana A, Taffe P, Weber R, Francioli P, et al. (2010) Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clin Infect Dis 51: e28-33.
33. Ndyomugyenyi R, Magnussen P, Clarke S, Ndyomugyenyi R, Magnussen P, et al. (2007) Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda. Malaria Journal 6: 39.
34. Siripattanapipong S, Leelayoova S, Mungthin M, Worapong J, Tan-Ariya P, (2008) Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients. Med Mycol 46: 389-392.
35. Nahimana A, Rabodonirina M, Bille J, Francioli P, Hauser PM, (2004) Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob Agents Chemother 48: 4301-4305.